Metabolic therapy in cardiology from the perspective of evidence-based medicine
Over the past few decades, various applications of the metabolic drugs have been extensively tested. Most of them affect oxygen-dependent processes, improving cellular metabolism and increasing tissue resistance to hypoxia and ischemia. The most promising candidates include components of the respira...
Saved in:
| Main Authors: | V. I. Kostin, O. A. Shangina, V. G. Shelikhov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Kemerovo State Medical University
2021-03-01
|
| Series: | Фундаментальная и клиническая медицина |
| Subjects: | |
| Online Access: | https://fcm.kemsmu.ru/jour/article/view/374 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
News of the Annual Congress of the European Society of Cardiology in Munich: Research to Help Practical Medicine
by: S. Yu. Martsevich
Published: (2018-11-01) -
Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
by: V. P. Mikhin, et al.
Published: (2012-02-01) -
Stem Cell Therapies in Canine Cardiology: Comparative Efficacy, Emerging Trends, and Clinical Integration
by: Ahmed Farag, et al.
Published: (2025-03-01) -
RETRACTED Congress of the American College of Cardiology (New Orleans, 2019): Clinical Findings
by: S. G. Kanorsky, et al.
Published: (2019-09-01) -
Evidence-based pharmacotherapy in cardiology. National guideline
by: S. Yu. Martsevich, et al.
Published: (2024-03-01)